Understanding rs1057516310: A Rare Genomic Variant
The variant rs1057516310 is a rare genetic change located in an intergenic region of the human genome. It has been identified in bioinformatics screenings for potential clinical significance, though its specific biological impact remains a subject of ongoing research.
What each genotype means
Carrier of enzyme deficiency variant
You carry one copy of a deletion variant (often noted as a 4-base pair deletion) in the HSD17B4 gene, which has been associated with bifunctional peroxisomal enzyme deficiency. As a carrier, you typically do not exhibit the condition, but you should discuss the implications of this finding with a genetic counselor or clinician.
This genotype is rare and is typically identified in clinical settings rather than general population screening.
Associated with enzyme deficiency
This genotype involves two copies of the deletion variant in the HSD17B4 gene, which is linked to bifunctional peroxisomal enzyme deficiency in clinical literature. Please consult with a medical geneticist or your primary healthcare provider to discuss the clinical relevance of this result for your health.
This genotype is extremely rare in the general population.
What is rs1057516310?
The identifier rs1057516310 refers to a specific single nucleotide polymorphism (SNP) cataloged in the dbSNP database. A SNP is a variation at a single position in a DNA sequence among individuals. This particular variant is classified as intergenic, meaning it is situated in the DNA sequence between genes rather than within a gene that codes for a protein. Because it does not reside in a protein-coding region, it does not directly alter the structure of a protein. Instead, researchers investigate whether such variants might influence how nearby genes are regulated or expressed. Identifying these variants is a key part of modern genomic research, as scientists work to map the entire landscape of human genetic diversity and understand how specific DNA changes might contribute to complex biological traits or health conditions.
The Role of Intergenic Variants
Intergenic regions were once referred to as 'non-coding' or 'junk' DNA, but modern genomics has revealed that these areas are often rich in regulatory elements. These elements, such as enhancers and promoters, act like switches that turn genes on or off or control the amount of protein produced. When a variant like rs1057516310 occurs in these regions, it has the potential to disrupt these regulatory switches. If a switch is altered, it could lead to changes in gene expression levels in specific tissues or under certain environmental conditions. While many intergenic variants have no observable effect on health, others are associated with disease risk or physiological traits. Determining the function of a specific intergenic variant requires extensive experimental validation, often involving cell-based assays or large-scale population studies to see if the variant correlates with a measurable biological outcome.
Research and Evidence Strength
The evidence supporting a clinical role for rs1057516310 is currently categorized as moderate. This classification typically arises from bioinformatics screenings where researchers use computational tools to predict whether a variant might be functional. While these tools are powerful for identifying candidates for further study, they do not provide definitive proof of a biological effect. In the context of the GWAS Catalog and other genomic repositories, a variant may be flagged because it appears in studies looking for associations with metabolic biomarkers or other complex traits. However, being flagged in a screening is only the first step. To move from a 'potential' association to a 'confirmed' clinical finding, researchers must replicate the results across diverse populations and perform functional studies to explain the mechanism. As of now, rs1057516310 remains a variant of interest that requires more robust, peer-reviewed evidence to fully understand its implications.
Population Frequency
The variant rs1057516310 is considered rare across human populations. In genomics, 'rare' generally indicates that the variant is found in a very small percentage of the population, often less than 1%. Because it is rare, it is difficult to study using standard genome-wide association studies (GWAS), which are best at detecting common variants that have small effects on common traits. Rare variants often require different statistical approaches, such as sequencing studies that look at specific families or cohorts with a shared condition. Because the frequency is low, the data available in public databases like gnomAD may be limited, making it challenging to determine if the variant is more common in specific ancestral groups or if it is distributed evenly across global populations. As more individuals are sequenced, our understanding of the frequency and distribution of this variant will likely become more precise.
What This Information Means for You
If you have encountered rs1057516310 in a genetic report, it is important to maintain perspective on the current state of genomic science. Most variants identified in bioinformatics screenings are not diagnostic, meaning they do not provide a definitive explanation for a health condition or a specific trait. Genetic information is complex, and the presence of a single variant rarely determines a health outcome on its own. You cannot use this information to make medical decisions or change your lifestyle without professional guidance. If you are concerned about your genetic results, the best course of action is to consult with a certified genetic counselor or a healthcare provider. They can help you interpret the findings in the context of your personal and family medical history. Always remember that genetic research is an evolving field, and what is considered a 'variant of interest' today may be better understood as more data becomes available in the future.
How common is this variant?
The variant rs1057516310 is classified as rare, appearing at a very low frequency across global populations in current genomic databases.
Frequently asked questions
Is rs1057516310 a disease-causing mutation?
There is currently no evidence to classify rs1057516310 as a disease-causing mutation. It is a rare variant identified in bioinformatics screenings, and its clinical significance remains to be determined by further research.
Should I be worried if I have this variant?
No, you should not be worried. Most genetic variants are neutral and do not have a significant impact on health. Genetic results should always be discussed with a qualified healthcare professional.
Can I use this information to change my diet or medication?
No. You should never make changes to your diet, lifestyle, or medication based on a single genetic variant. Always consult with your doctor or pharmacist before making any health-related decisions.
Why is this variant called 'intergenic'?
It is called intergenic because it is located in the DNA sequence between genes. It does not sit within a gene that provides instructions for making a protein.
Where can I find more information about this SNP?
You can search for the rsID on public databases like the NCBI dbSNP website or the GWAS Catalog. These resources provide the most up-to-date scientific data on known genetic variants.
Sources & further reading
Educational information only, last refreshed 10/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1057516310?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant in the TYK2 gene is identified as a shared causal signal in the genetic architecture of psoriasis and rheumatoid arthritis.
This TYK2 variant shows evidence of antagonistic pleiotropy, with opposite effects on the risk of psoriasis versus rheumatoid arthritis.
This SNP acts as an intermediate allele tag for the C9orf72 repeat expansion, which is linked to both ALS risk and longevity outcomes.
This variant in the CDKN2B-AS1 long noncoding RNA gene is associated with extreme longevity in genome-wide association studies.
This variant has been identified as a shared genetic signal between longevity and Alzheimer's disease risk.
A variant in the ALOX5 gene associated with potential modulation of inflammatory responses to dietary factors.
